TiclopidineAspirinPlatelet Aggregation InhibitorsPurinergic P2Y Receptor AntagonistsPlatelet Function TestsReceptors, Purinergic P2Y12Platelet AggregationDrug Therapy, CombinationAnti-Inflammatory Agents, Non-SteroidalHemorrhageAcute Coronary SyndromeThiophenesBlood PlateletsPlatelet ActivationThrombosisTreatment OutcomeThromboxane B2Angioplasty, Balloon, CoronaryMyocardial InfarctionAryl Hydrocarbon HydroxylasesDrug ResistanceCyclooxygenase InhibitorsPostoperative HemorrhageDrug InteractionsFibrinolytic AgentsAnticoagulantsDouble-Blind MethodSalicylatesBleeding TimeStentsProton Pump InhibitorsCoronary ThrombosisPurinergic P2 Receptor AntagonistsDose-Response Relationship, DrugPlatelet Glycoprotein GPIIb-IIIa ComplexAdenosine DiphosphateTime FactorsStrokeProspective StudiesWarfarinCoronary Artery DiseaseRisk FactorsGastrointestinal HemorrhageDipyridamoleDrug Administration ScheduleThrombelastographySodium SalicylatePiperazinesPercutaneous Coronary InterventionDrug-Eluting StentsRisk AssessmentPremedicationP-SelectinAsthma, Aspirin-InducedRecurrenceFollow-Up StudiesCross-Over StudiesTablets, Enteric-CoatedRandomized Controlled Trials as TopicCyclooxygenase 1Cardiovascular DiseasesThromboxane A2PharmacogeneticsProstaglandin-Endoperoxide SynthasesThromboxanesAngina, UnstableGraft Occlusion, VascularIbuprofenCoronary DiseaseHeparinCyclooxygenase 2 InhibitorsDrug HypersensitivityCytochrome P-450 CYP3AThromboembolism